# The Neko Full-Body Scan: What $499 Gets You in Advanced Preventive Health
A new whole-body scanning service called Neko is offering comprehensive health mapping for about $500. The experience involves mapping 1,596 skin markings and conducting detailed cardiovascular and blood assessments in a single hour-long appointment. The question emerging from early adopters isn't just whether the technology works, but whether the price tag justifies what participants actually learn.
The Neko scan represents a shift toward preventive medicine that moves beyond traditional annual checkups. The procedure combines several screening tools into one session: detailed skin analysis (relevant for melanoma and other dermatological concerns), heart function testing, and blood work. For people concerned about early disease detection, this consolidation offers convenience. Rather than scheduling separate appointments with a dermatologist, cardiologist, and primary care physician, one visit covers multiple bases.
The 1,596 skin markings catalogued during the scan create a baseline record. This approach mirrors emerging research in dermatology that recognizes mole burden as a risk factor for melanoma. By establishing a detailed map, future scans can identify which markings have changed, grown, or shifted in appearance. Changes detected early can prompt faster intervention from a dermatologist.
The cardiovascular component addresses one of the leading causes of preventable death. Heart disease kills more Americans than any other condition. Testing heart function and blood markers in one visit makes practical sense, especially for people with family history or lifestyle risk factors. The blood work likely measures cholesterol, blood pressure derivatives, and inflammatory markers like high-sensitivity C-reactive protein.
However, the value proposition hinges on what happens after the scan. Data collection alone changes nothing. People need actionable guidance and integration with their existing healthcare providers. A $499 scan only matters if the results lead to meaningful behavioral change or if findings catch something that would have been missed during standard care. Without clear follow-up protocols and communication with your doctor, the scan becomes an expensive snapshot.
The accessibility question also matters. A $499 annual scan is feasible for affluent patients but excludes many Americans. Traditional insurance-covered screening through primary care physicians remains free or low-cost for most insured patients. Neko targets health-conscious individuals willing to pay for convenience and comprehensiveness rather than people who need preventive care most.
Research on whole-body scanning shows mixed results. Studies demonstrate that some screening approaches do catch early cancers and cardiovascular disease. Yet comprehensive screening also increases the odds of finding incidental findings, benign variations that trigger additional testing and anxiety without improving health outcomes. The concept of "overdiagnosis" applies here. Not every finding requires treatment, and knowing about everything in your body isn't universally beneficial.
For someone with specific health concerns, family history of early heart disease or cancer, or someone who values data-driven health monitoring, the Neko scan offers organized baseline information. For generally healthy people without compelling risk factors, the value becomes more debatable. Traditional screening guidelines from organizations like the American Cancer Society and American Heart Association provide clear recommendations about who needs what testing at what age. Neko works outside those frameworks.
The technology itself deserves credit for making multiple screenings faster and more convenient. Whether that convenience justifies $499 depends entirely on your risk profile, access to regular primary care, and how you plan to act on the results.